Monoclonal antibody treatment

Allina Health is offering monoclonal antibody treatment to eligible individuals.

Monoclonal antibody infusion therapy is used to treat a person who has COVID-19. Read an information sheet with more details about this treatment.

The current eligibility criteria* for treatment at Allina Health is that you:

  • are age 18 or older
  • have tested positive for COVID-19 (RT-PCR nasopharyngeal swab or antigen test)
  • have mild to moderate symptoms (i.e., you are not in the hospital and you do not need oxygen)
  • must be able to have the infusion within 10 days of when your symptoms started

You are ineligible* (not able to have this treatment at Allina Health) if you meet one of these criteria:

  • are younger than age 18
  • are pregnant or breastfeeding
  • have been admitted to the hospital for COVID-19
  • need post-exposure prophylaxis (This treatment is not authorized by the FDA to be used to prevent COVID-19.)

*Due to limited capacity, Allina Health is limiting people based on the above criteria although the U.S. Food and Drug Administration (FDA) Emergency Use Authorization has more expanded criteria. 

All patients who have had COVID-19 tests done at an Allina Health location and are positive will be asked if they want to opt in to the monoclonal antibody infusion therapy treatment program. Patients who have had tests done outside of Allina Health can be opted in via their primary care provider or via the MDH MNRAP program.

Allina Health will contact eligible patients to confirm they meet the eligibility criteria and then schedule them for their appointment.